Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for 10+ years, this year for PurpleStride Miami and Broward-Palm Beach ...

We want every patient with pancreatic cancer and their caregiving team to consider PanCAN Patient Services a partner in navigating diet and nutrition.

We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic cancer.

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit highlights the latest advances in precision medicine ...

At 15, Reyna is a two-year pancreatic cancer survivor. She’s taking steps to end the disease at PanCAN PurpleStride 2026 and wants you to join her!

PanCAN Patient Services is the place to contact when facing pancreatic cancer. Our highly trained and compassionate Case Managers provide free, personal one-to-one support and information about the ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.

American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.

For the first time in more than a decade, the FDA has approved a new first-line treatment for patients with metastatic pancreatic cancer. After a clinical trial showed a positive survival benefit, the ...

Pancreatic cancer at any stage can create challenges in a patient’s diet and change nutritional needs. In recognition of June as National Fresh Fruit and Vegetable Month, we asked Maria Petzel, senior ...

The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...